NEA Management Company, LLC Q2 2019 Filing
Filed August 7, 2019
Portfolio Value
$1.4T
Holdings
44
Report Date
Q2 2019
Filing Type
13F-HR
All Holdings (44 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —RA PHARMACEUTICALS INC | 6,138,797 | $184.6B | 12.93% | |
| 2 | GLYCEURGLYCOMIMETICS INC | 9,089,041 | $108.3B | 7.59% | |
| 3 | RYTMRHYTHM PHARMACEUTICALS INC | 4,912,306 | $108.1B | 7.57% | |
| 4 | CRSPCRISPR THERAPEUTICS AG | 2,090,678 | $98.5B | 6.90% | |
| 5 | ALLKGUSDALLAKOS INC | 2,268,188 | $98.3B | 6.88% | |
| 6 | —PHASEBIO PHARMACEUTICALS INC | 6,643,704 | $87.2B | 6.11% | |
| 7 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 15,832,611 | $63.6B | 4.46% | |
| 8 | SENS1GBPSENSEONICS HOLDINGS INC | 30,888,266 | $63.0B | 4.41% | |
| 9 | —EPIZYME INC | 4,377,518 | $54.9B | 3.85% | |
| 10 | —OBSEVA SA | 4,586,563 | $51.9B | 3.63% | |
| 11 | —MERSANA THERAPEUTICS INC | 11,894,267 | $48.2B | 3.37% | |
| 12 | ARDXARDELYX INC | 15,335,047 | $41.3B | 2.89% | |
| 13 | TPIVDEURMARKER THERAPEUTICS INC | 5,000,000 | $39.6B | 2.77% | |
| 14 | —SYNLOGIC INC | 4,229,410 | $38.5B | 2.70% | |
| 15 | AUPHAURINIA PHARMACEUTICALS INC | 5,172,683 | $34.0B | 2.38% | |
| 16 | —DERMIRA INC | 3,506,649 | $33.5B | 2.35% | |
| 17 | TRVITREVI THERAPEUTICS INC | 4,429,804 | $33.2B | 2.33% | |
| 18 | —GENOCEA BIOSCIENCES INC | 7,225,676 | $28.3B | 1.98% | |
| 19 | —MILLENDO THERAPEUTICS INC | 1,766,779 | $20.4B | 1.43% | |
| 20 | LQDALIQUIDIA TECHNOLOGIES INC | 2,486,062 | $19.9B | 1.39% | |
| 21 | —AVEO PHARMACEUTICALS INC | 25,243,865 | $16.9B | 1.18% | |
| 22 | BEBLOOM ENERGY CORP | 1,333,333 | $16.4B | 1.15% | |
| 23 | LXRXLEXICON PHARMACEUTICALS INC | 2,382,286 | $15.0B | 1.05% | |
| 24 | —AFFIMED NV | 5,138,888 | $14.7B | 1.03% | |
| 25 | MEIPUSDMEI PHARMA INC | 5,720,572 | $14.3B | 1.00% | |
| 26 | —STRONGBRIDGE BIOPHARMA PLC | 4,141,308 | $13.0B | 0.91% | |
| 27 | —DASAN ZHONE SOLUTIONS INC | 956,255 | $12.4B | 0.87% | |
| 28 | CSBRCHAMPIONS ONCOLOGY INC | 1,562,500 | $12.2B | 0.86% | |
| 29 | SURFUSDSURFACE ONCOLOGY INC | 3,315,149 | $9.3B | 0.65% | |
| 30 | RIGLUSDRIGEL PHARMACEUTICALS INC | 3,243,150 | $8.5B | 0.59% | |
| 31 | VRNAVERONA PHARMA PLC | 1,219,674 | $6.2B | 0.44% | |
| 32 | —PROTEOSTASIS THERAPEUTICS INC | 5,556,778 | $5.4B | 0.38% | |
| 33 | ASNSUSDX4 PHARMACEUTICALS INC | 333,333 | $5.0B | 0.35% | |
| 34 | ERYP1EURERYTECH PHARMA SA | 625,000 | $4.5B | 0.31% | |
| 35 | —TREVENA INC | 3,811,691 | $3.9B | 0.28% | |
| 36 | CTIC1USDCTI BIOPHARMA CORP | 3,750,000 | $3.2B | 0.23% | |
| 37 | —REGULUS THERAPEUTICS INC | 2,052,455 | $2.6B | 0.18% | |
| 38 | —TRACON PHARMACEUTICALS INC | 3,467,181 | $2.4B | 0.17% | |
| 39 | —ENDOLOGIX INC | 249,021 | $1.8B | 0.13% | |
| 40 | XENEXENON PHARMACEUTICALS INC | 182,754 | $1.8B | 0.13% | |
| 41 | —SUNESIS PHARMACEUTICALS INC | 1,298,274 | $943.0M | 0.07% | |
| 42 | —AKARI THERAPEUTICS PLC | 452,167 | $913.0M | 0.06% | |
| 43 | TREURTRILLIUM THERAPEUTICS INC | 2,100,000 | $691.0M | 0.05% | |
| 44 | —ACHAOGEN INC | 5,215,128 | $99.0M | 0.01% |